Dr. Ji said in an interview that the Abivirtinib phase two trial will begin in August and last 4-6 weeks. He also said that Abivirtinib would be a great drug to combine with CAR-T cancer drugs to prevent cytokine storm which has been a real problem. It has already been shown to be safe and effective in solid and blood cancers. This a BLOCKBUSTER folks. https://finance.yahoo.com/video/sorrento-gets-fda-approval-covid-140900770.html
"The refusal of the real is the number one dogma of our time" Rene Girard